Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Clinical trial NCT06086340 · COMPLETED
Trial details
- NCT number
- NCT06086340
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-29
- Primary completion
- 2024-01-24
- Enrollment
- 779
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.